Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

NASA Deep Space Navigation engineer presents at Naval Hill Planetarium
2017-03-30

Description: NASA Deep Space Navigation engineer  Tags: NASA Deep Space Navigation engineer

From the left: Chris du Plessis; US Consulate, Johannesburg,
Prof Petrus Meintjes; Dept of Physics UFS, Christopher Jacobs;
NASA, and Anthony Deaton; US Consulate Johannesburg.
Photo: Rulanzen Martin

The University of the Free State (UFS) hosted NASA Deep Space engineer Christopher Jacobs on 27 March 2017 at the Bloemfontein Campus. The engagement was hosted by Prof Matie Hoffman of the Department of Physics and the Department of Institutional Advancement, in collaboration with the US Consulate General in Johannesburg.

Jacobs is stationed at NASA’s Jet Propulsion Laboratory (JPL) at the California Institute of Technology and has served as the Reference Frame Calibration task manager for 25 years. In this role he has been responsible for delivering the reference frames used to navigate NASA missions such as the Mars Science Laboratory to planetary targets.

His visit to the UFS included a presentation to the Department of Astrophysics at the Faculty of Natural and Agricultural Sciences and at the Naval Hill Planetarium in Bloemfontein where he spoke on Stellar GPS: Navigating the Solar System. He also spoke about the latest research and developments at NASA in Astrometry. The visit will establish and develop shared interests and possible collaboration with UFS and other institutions of interest in the country. “South Africa, because of its well-placed geographic location in the southern hemisphere, holds a lot of answers to astronomy,” Jacobs said.

He has an active interest in professional and public education, and outreach, having given public lectures around the world. “Astronomy brings people together and is a point of common interest that is key in solving environmental and geographical challenges such as climate change, therefore global cooperation is important,” he said.

Prof Hoffman welcomed the initiative by the US Consulate and the possible outcomes of joint efforts to position the UFS as a key partner in South Africa on NASA’s astronomy projects. In the coming weeks Jacobs will speak at high schools in Gauteng including the Mae Jemison US Science Reading Room in Mamelodi, Pretoria, a centre that is focused on promoting science education.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept